Encompass Health’s (EHC) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Encompass Health (NYSE:EHC) in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a $110.00 target price on the stock.

Several other brokerages have also recently weighed in on EHC. Truist Financial reiterated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp increased their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Monday. StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday, February 7th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Finally, Barclays lifted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Performance

EHC opened at $99.37 on Tuesday. The firm has a 50 day moving average of $96.14 and a two-hundred day moving average of $95.41. The firm has a market capitalization of $10.01 billion, a PE ratio of 22.28, a P/E/G ratio of 1.18 and a beta of 0.90. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a 12-month low of $72.38 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. On average, analysts anticipate that Encompass Health will post 4.76 EPS for the current year.

Institutional Trading of Encompass Health

Several institutional investors have recently added to or reduced their stakes in EHC. TD Private Client Wealth LLC boosted its holdings in Encompass Health by 2,870.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after acquiring an additional 7,089 shares during the period. Los Angeles Capital Management LLC increased its stake in Encompass Health by 532.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after buying an additional 42,338 shares during the period. Pathstone Holdings LLC lifted its holdings in Encompass Health by 54.5% during the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after buying an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. grew its stake in shares of Encompass Health by 43.8% in the third quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after acquiring an additional 20,242 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Encompass Health by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after acquiring an additional 20,547 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.